Telix制药公司完成比利时的循环器安装,预定在2025年初生产重要的医用同位素。 Telix Pharmaceuticals completes cyclotron installation in Belgium, set to produce vital medical isotopes in early 2025.

Telix制药公司已完成在比利时新制造设施安装两台环子,用于生产关键的医用同位素,如-68和-89。 Telix Pharmaceuticals has finished installing two cyclotrons at its new manufacturing facility in Belgium, set to produce key medical isotopes like gallium-68 and zirconium-89. 一个回旋加速器将支持临床和商业需求，而另一个将专注于研究。 One cyclotron will support clinical and commercial needs, while the other will focus on research. 该设施预计将于2025年初开始运作,将为欧洲、中东和非洲区域提供服务,增加获得放射药剂的机会。 The facility, expected to begin operations in early 2025, will serve the Europe, Middle East, and Africa regions, enhancing access to radiopharmaceuticals.